X T L Biopharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Bioline Rx USD 6.6M 116K Sep/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
X T L Biopharmaceuticals USD 0 0 Dec/2024